These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8976553)

  • 1. Strategy to design peptide inhibitors: structure of a complex of proteinase K with a designed octapeptide inhibitor N-Ac-Pro-Ala-Pro-Phe-DAla-Ala-Ala-Ala-NH2 at 2.5 A resolution.
    Saxena AK; Singh TP; Peters K; Fittkau S; Betzel C
    Protein Sci; 1996 Dec; 5(12):2453-8. PubMed ID: 8976553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the complex of proteinase K with a substrate analogue hexapeptide inhibitor at 2.2-A resolution.
    Betzel C; Singh TP; Visanji M; Peters K; Fittkau S; Saenger W; Wilson KS
    J Biol Chem; 1993 Jul; 268(21):15854-8. PubMed ID: 8340410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a complex formed between proteolytically-generated lactoferrin fragment and proteinase K.
    Singh TP; Sharma S; Karthikeyan S; Betzel C; Bhatia KL
    Proteins; 1998 Oct; 33(1):30-8. PubMed ID: 9741842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of a ternary complex of proteinase K, mercury, and a substrate-analogue hexa-peptide at 2.2 A resolution.
    Saxena AK; Singh TP; Peters K; Fittkau S; Visanji M; Wilson KS; Betzel C
    Proteins; 1996 Jun; 25(2):195-201. PubMed ID: 8811735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformation.
    Hoang HN; Bryant GK; Kelso MJ; Beyer RL; Appleton TG; Fairlie DP
    Inorg Chem; 2008 Oct; 47(20):9439-49. PubMed ID: 18788796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
    De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
    Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray and model-building studies on the specificity of the active site of proteinase K.
    Betzel C; Bellemann M; Pal GP; Bajorath J; Saenger W; Wilson KS
    Proteins; 1988; 4(3):157-64. PubMed ID: 3237715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and application of MeOSuc-Ala-Ala-Pro-Phe-CH2Cl as potent proteinase K inhibitor.
    Kore AR; Shanmugasundaram M; Hoang Q; Kuo M; Chapman LM; Chen HH
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1296-300. PubMed ID: 19211247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of specific structures using alpha,beta-dehydro-phenylalanine residues: synthesis, crystal structure, and molecular conformation of Boc-L-Val-delta Phe-delta Phe-L-Val-delta Phe-delta Phe-L-Val-OCH3, a 3(10)-helical heptapeptide.
    Mitra SN; Dey S; Karthikeyan S; Singh TP
    Biopolymers; 1997 Jan; 41(1):97-105. PubMed ID: 8986122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid state structural analysis of the cyclooctapeptide cyclo- (Pro1-Pro-Phe-Phe-Ac6c-Ile-D-Ala-Val8).
    Saviano M; Isernia C; Rossi F; Di Blasio B; Iacovino R; Mazzeo M; Pedone C; Benedetti E
    Biopolymers; 2000 Feb; 53(2):189-99. PubMed ID: 10679623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of peptides using alpha, beta-dehydro-residues: synthesis, crystal structure and molecular conformation of N-Boc-L-Val-delta Phe-delta Phe-L-Ala-OCH3.
    Bhatia S; Dey S; Kaur P; Singh TP
    J Pept Sci; 1996; 2(6):357-63. PubMed ID: 9230463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV.
    Bergmann EM; Cherney MM; Mckendrick J; Frormann S; Luo C; Malcolm BA; Vederas JC; James MN
    Virology; 1999 Dec; 265(1):153-63. PubMed ID: 10603326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
    J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational investigation of alpha,beta-dehydropeptides. XV: N-acetyl-alpha,beta-dehydroamino acid N 'N '-dimethylamides: conformational properties from infrared and theoretical studies.
    Broda MA; Siodłak D; Rzeszotarska B
    J Pept Sci; 2005 Sep; 11(9):546-55. PubMed ID: 15782429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.